Evidence map›Paper›PMID 28481721›Full record

ArticleVirulence2017

S. oralis activates the Efg1 filamentation pathway in C. albicans to promote cross-kingdom interactions and mucosal biofilms.

Hongbin Xu, Takanori Sobue, Martinna Bertolini, Angela Thompson, Margaret Vickerman, Clarissa J Nobile, Anna Dongari-Bagtzoglou

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Cannabidiol (CBD) InhibitsInternational journal of dentistry · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. The Oral Microbiome: A Key Determinant of Oral Health.Advances in experimental medicine and biology · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Cross-kingdom interaction betweenFrontiers in microbiology · 2022
    Review
  19. Recent Advances and Opportunities in the Study ofFrontiers in cellular and infection microbiology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hongbin Xua School of Dental Medicine, University of Connecticut , Farmington , CT , USA.
Takanori Sobuea School of Dental Medicine, University of Connecticut , Farmington , CT , USA.
Martinna Bertolinia School of Dental Medicine, University of Connecticut , Farmington , CT , USA.
Angela Thompsona School of Dental Medicine, University of Connecticut , Farmington , CT , USA.
Margaret Vickermanb School of Dental Medicine, SUNY Buffalo , Buffalo , NY , USA.
Clarissa J Nobilec School of Natural Sciences, University of California , Merced, Merced , CA , USA.
Anna Dongari-Bagtzogloua School of Dental Medicine, University of Connecticut , Farmington , CT , USA.
University of Connecticut · USUniversity at Buffalo, State University of New York · USUniversity of California, Merced · US

Funding

Oral Epithelial Cells, Candida and PMN ActivationR01DE013986 · NIDCR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI Anna I Dongari-Bagtzoglou · 2000 to 2026
$9.2M
NIDCR NIH HHS R01 DE013986
6 · The paper itself

Abstract

Candida albicans and Streptococcus oralis are ubiquitous oral commensal organisms. Under host-permissive conditions these organisms can form hypervirulent mucosal biofilms. C. albicans biofilm formation is controlled by 6 master transcriptional regulators: Bcr1, Brg1, Efg1, Tec1, Ndt80, and Rob1. The objective of this work was to test whether any of these regulators play a role in cross-kingdom interactions between C. albicans and S. oralis in oral mucosal biofilms, and identify downstream target gene(s) that promote these interactions. Organotypic mucosal constructs and a mouse model of oropharyngeal infection were used to analyze mucosal biofilm growth and fungal gene expression. By screening 6 C. albicans transcription regulator reporter strains we discovered that EFG1 was strongly activated by interaction with S. oralis in late biofilm growth stages. EFG1 gene expression was increased in polymicrobial biofilms on abiotic surfaces, mucosal constructs and tongue tissues of mice infected with both organisms. EFG1 was required for robust Candida-streptococcal biofilm growth in organotypic constructs and mouse oral tissues. S. oralis stimulated C. albicans ALS1 gene expression in an EFG1-dependent manner, and Als1 was identified as a downstream effector of the Efg1 pathway which promoted C. albicans-S. oralis coaggregation interactions in mixed biofilms. We conclude that S. oralis induces an increase in EFG1 expression in C. albicans in late biofilm stages. This in turn increases expression of ALS1, which promotes coaggregation interactions and mucosal biofilm growth. Our work provides novel insights on C. albicans genes which play a role in cross-kingdom interactions with S. oralis in mucosal biofilms.

Indexed as

BiofilmsAnimalsBacterial ProteinsCandida albicansDNA-Binding ProteinsFemaleFungal ProteinsMiceMice, Inbred C57BLMouth MucosaStreptococcus oralisTranscription FactorsBacterial ProteinsDNA-Binding ProteinsEFG1 protein, Candida albicansFungal ProteinsTranscription FactorsALS1Candidacross-kingdom biofilmEFG1oral mucosaStreptococcus

Identifiers

PMID28481721
PMCPMC5810487
OpenAlexW2613898821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.